Polyhydroxy acid (PHA) guide: the gentlest exfoliant and when to use it

Polyhydroxy acids (PHAs) are the third generation of chemical exfoliants — after AHAs and BHAs — designed to provide the surface renewal benefits of acid exfoliation with a significantly gentler delivery profile. They are not simply weaker AHAs; their structural differences produce distinct properties that make them the preferred exfoliant for specific skin types and conditions. Here is the complete guide.

Structure and mechanism

What makes PHAs different from AHAs

AHAs (glycolic, lactic, mandelic) have a single hydroxyl (-OH) group adjacent to the carboxylic acid group. This relatively simple structure allows the molecule to penetrate the stratum corneum at a rate governed primarily by molecular weight.

PHAs have multiple hydroxyl groups on the same molecule — hence "poly" (many) hydroxy acids:

Gluconolactone: C₆H₁₀O₆ — a lactone (cyclic ester) of gluconic acid; contains 4 hydroxyl groups; MW 178 Da
Lactobionic acid: C₁₂H₂₂O₁₂ — a disaccharide acid (galactose + gluconic acid); contains 8 hydroxyl groups; MW 358 Da
Galactose: Less commonly used; monosaccharide; multiple hydroxyls

Why multiple hydroxyls change the behavior:

Larger effective molecular size: Multiple hydroxyl groups increase both molecular weight and the molecule's interaction with water (hydrogen bonding). Lactobionic acid at 358 Da is more than 4× the size of glycolic acid — penetration rate is dramatically slower.
Hygroscopic (water-attracting) properties: The multiple -OH groups bind water molecules through hydrogen bonding — PHAs are intrinsically humectant. Unlike AHAs, which are purely exfoliants, PHAs simultaneously exfoliate and attract moisture to the treated skin.
Chelating activity: PHAs chelate (bind) metal ions, including iron, which catalyzes the Fenton reaction generating hydroxyl radicals. By chelating iron, PHAs may reduce UV-stimulated ROS-driven oxidative stress — a modest antioxidant-like secondary benefit not shared by simple AHAs.

The exfoliation mechanism

PHAs work by the same corneodesmosome-digestion mechanism as AHAs — low pH accelerates serine protease activity → loosens corneocyte cohesion → accelerated desquamation. The slower penetration means:

The acid reaches effective concentrations in the stratum corneum more gradually
Peak irritation is lower than equivalent-concentration glycolic acid
Exposure to the viable epidermis (where the nerve endings that register stinging are located) is reduced

The sensitivity advantage: clinical evidence

PHAs in sensitive and rosacea-prone skin

The primary clinical rationale for PHAs over AHAs is their superiority in sensitive, reactive, or rosacea-prone skin:

Bernstein et al. (2004, Cutis): Head-to-head comparison of gluconolactone 14% vs. glycolic acid 10% in patients with sensitive facial skin. Gluconolactone produced equivalent improvement in skin texture and hydration with significantly less stinging, erythema, and irritation — the defining study establishing PHAs as the sensitive-skin-appropriate acid exfoliant.

PHA in rosacea: The anti-inflammatory properties of gluconolactone (partially mediated by its iron-chelating antioxidant activity) and the absence of the acute stinging response make PHAs more tolerable in rosacea-prone skin than glycolic or lactic acid. Multiple dermatologist-authored case series document PHAs as a viable exfoliant option for mild rosacea where AHAs would trigger flares.

Compatibility with retinoids

A critical practical advantage: PHAs can be used on the same night as retinoids in many protocols — something generally avoided with AHAs and BHAs (which produce cumulative barrier disruption when combined with retinoids).

The rationale:

PHA's slow penetration rate means less acute barrier perturbation
The built-in humectant effect partially offsets retinoid-induced dryness
At concentrations used in leave-on products (4–10%), gluconolactone combined with low-concentration retinoids (retinol 0.1–0.3%) has been used in combination formulations (NeoStrata's Skin Active Intensive Eye Therapy, for example, contains gluconolactone alongside retinol)

Caveat: This compatibility applies to low-to-moderate concentrations; high-concentration PHAs (>10%) combined with prescription tretinoin still carry cumulative irritation risk and should follow a cycling protocol.

Evidence for specific applications

Anti-aging and texture

PHAs produce the same surface renewal mechanism as AHAs — accelerated corneocyte turnover → smoother surface texture; mild collagen stimulation in the papillary dermis from the wound-healing signaling of accelerated turnover.

Green et al. (2009, Journal of Cosmetic Dermatology): PHA-containing cream significantly improved skin texture, tone, and hydration scores vs. vehicle in a 12-week controlled study — with no significant irritation in a mixed skin-type population that included rosacea and sensitive skin subjects.

Antioxidant and photoprotection adjunct

PHAs' iron-chelating activity reduces free-radical cascade driven by UV-exposed iron-porphyrin complexes in the skin. While PHAs do not replace SPF, their antioxidant secondary activity is a genuine (if minor) complementary benefit that AHAs lack.

Post-procedure maintenance

After in-office procedures (laser, chemical peels, microneedling), the recovering skin barrier is too compromised for standard AHAs during the healing phase. PHAs — with their slower penetration, humectant properties, and lower irritation profile — are used by some clinicians as the first exfoliant reintroduced post-procedure, typically starting 4–6 weeks after treatment.

Who should use PHAs

Ideal candidates:

Sensitive skin that stings or flushes with glycolic or lactic acid
Rosacea-prone skin requiring chemical exfoliation without triggering flares
Skin barrier repair phase — transitioning back to exfoliants after a barrier reset
First-time chemical exfoliant users building tolerance
Combination with retinoids when single-night active stacking is preferred
Periorbital area — where AHAs are sometimes too irritating; gluconolactone in low concentration is one of the gentler options for the thin eye-area skin

When AHAs are preferable to PHAs:

Non-sensitive skin seeking faster visible results
Higher-concentration at-home or in-office exfoliation for significant photoaging, melasma, or deep texture concerns
When cost is a factor — PHAs are less widely available and often more expensive than AHA products

Formulations and usage

Leave-on products (4–10% gluconolactone or lactobionic acid):

Apply after cleansing, before moisturizer
Evening or morning use — PHAs are less photosensitizing than glycolic acid at typical concentrations, though AM SPF remains essential
Daily use appropriate from the outset for most skin types

In-office PHA peels (20–40%): Less common than AHA peels but used in sensitive skin protocols; minimal downtime; appropriate for rosacea-prone or sensitized skin that cannot tolerate standard peels.

Key products: NeoStrata is the dominant PHA brand (gluconolactone was patented and developed by NeoStrata's founders, Van Scott and Yu, who pioneered the entire AHA/PHA field). ISDIN, First Aid Beauty, and Paula's Choice also offer PHA-containing formulations.

Looking for a skincare or chemical peel consultation? Browse med spa providers on MedSpot →